Polydex Pharma Stock Price (OTCMKTS:POLXF)

Add to My Stocks
$0.99 $0.01 (1.02%) POLXF stock closing price Sep 19, 2018 (Closing)
Prev Close* : $0.98
Market Cap:
Day Low: $0.99
52 Week Low: $0.97
Open: $1.03
Volume: $400
Day High: $1.03
52 Week High: $1.36

Latest Stock Market News

Latest Articles

POLXF Stockcharts

View POLXF PE ratio, PS ratio stocks charts and compare with peers.
Note: Compare Polydex Pharma stock price history with the index and industry peers.

Polydex Pharma Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Polydex Pharma Returns

(return on equity)

Polydex Pharma Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

POLXF Industry Peers

Company Price Change (%)
Integrated Biopharma (INBP)0.180 (0%)
Telik (MBVX)0.40.04 (11.11%)
Neptune Tech. & Bio. (NEPT)4.710.44 (10.3%)
Dnib Unwind Inc (BINDQ)0.150 (0%)
Neptune Tech. & Bio. (NEPT)4.710.44 (10.3%)
Neovasc (NVCN)0.030 (0%)
Zogenix (ZGNX)47.051.6 (3.29%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MOLECULAR TEMPL (MTEM)6.252.15 (52.44%)
Neptune Tech. & Bio. (NEPT)4.710.44 (10.3%)
Infinity Pharma (INFI)2.310.18 (8.45%)
Pacira Pharma (PCRX)51.353.5 (7.31%)
Aratana Therapeutics (PETX)5.840.39 (7.16%)
Achaogen (AKAO)4.560.28 (6.54%)
La Jolla Pharma (LJPC)22.071.12 (5.35%)
Top gainers from Medical-Drugs industry
* As of Sep 20, 2018
CompanyPriceChange (%)
PTC Therapeutics (PTCT)45.371.82 (3.86%)
USANA Health Sciences (USNA)119.354.75 (3.83%)
Esperion Therapeutics (ESPR)45.571.69 (3.58%)
ArQule (ARQL)4.850.17 (3.39%)
Zogenix (ZGNX)47.051.6 (3.29%)
Nektar Therapeutics (NKTR)56.691.64 (2.81%)
Durect (DRRX)1.10.03 (2.65%)
Top losers from Medical-Drugs industry
* As of Sep 20, 2018

Polydex Pharma Financial Statements

income statement20182017201620152014
Net Sales or Revenues5.27M6.62M6.04M5.37M5.96M
Net Income--1.27M--
Total Operating Expense00000
View Polydex Pharma income statement
balance sheet20182017201620152014
Total Assets7.32M6.7M5.81M5.67M5.76M
Total Liabilities1.56M1.66M1.83M2.5M2.62M
Shareholders Equity5.76M5.04M3.98M3.17M3.13M
View Polydex Pharma balance sheet
cash flow statement20182017201620152014
Net Increase (Decrease) in Assets Liabilities-0.43M-0.54M-0.39M-0.01M-0.11M
Net Cash from (used by) Operating Activities-----
Increase (Decrease) in Prop Plant And Equipment-0.37M-0.29M-0.19M-0.36M-0.29M
View Polydex Pharma cash flow statement

Polydex Pharma Stock Message Board

Polydex Pharma stock price ended the last trading day at $0.99. The total market value as denoted by $3.32M for Polydex Pharma, is the market value of the company's outstanding shares. A value investor must look at the fundamentals of a stock, and perform Polydex Pharma valuation, even though in the short-term, sentiment and current breaking news might affect Polydex Pharma stock price.

For recognizing and analyzing the real performance of Polydex Pharma stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume number in Polydex Pharma stock quote data shows the number of shares traded. For Ex: 400 Polydex Pharma shares were traded as of last trading day, as seen from Polydex Pharma stock chart. Polydex Pharma paid 0.00 stock dividends to its shareholders during last quarter. One can observe stock price trends and check for volatility by checking Polydex Pharma stock price history.